Stockscreener 앱 받기
73.53
1.20%
-0.89
시간 외 거래:
73.53
전일 마감가:
$74.42
열려 있는:
$74.55
하루 거래량:
351.09K
Relative Volume:
0.49
시가총액:
$3.69B
수익:
$379.25M
순이익/손실:
$-77.34M
주가수익비율:
-45.61
EPS:
-1.6122
순현금흐름:
$-27.87M
1주 성능:
+1.13%
1개월 성능:
+0.53%
6개월 성능:
+88.06%
1년 성능:
+87.00%
1일 변동 폭
$72.14
$74.55
1주일 범위
$71.66
$77.00
52주 변동 폭
$36.88
$78.54
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
명칭
Mirum Pharmaceuticals Inc
전화
650-667-4085
주소
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
MIRM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
73.53 | 3.74B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-24 | 개시 | TD Cowen | Buy |
| 2025-08-11 | 재개 | Stifel | Buy |
| 2025-05-19 | 재개 | H.C. Wainwright | Buy |
| 2024-04-17 | 개시 | Stifel | Buy |
| 2023-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-11-13 | 개시 | Morgan Stanley | Overweight |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-17 | 재개 | Evercore ISI | Outperform |
| 2023-09-20 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-01 | 개시 | Citigroup | Buy |
| 2021-09-20 | 개시 | JP Morgan | Overweight |
| 2020-08-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-06-25 | 개시 | Robert W. Baird | Outperform |
| 2019-08-12 | 개시 | Citigroup | Buy |
| 2019-08-12 | 개시 | Evercore ISI | Outperform |
| 2019-08-12 | 개시 | Guggenheim | Buy |
| 2019-08-12 | 개시 | ROTH Capital | Buy |
| 2019-08-12 | 개시 | Raymond James | Outperform |
모두보기
Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스
Is Mirum Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com
Is it time to cut losses on Mirum Pharmaceuticals Inc.Trade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Technical signs of recovery in Mirum Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - newser.com
Mirum Pharmaceuticals (NASDAQ:MIRM) Is Carrying A Fair Bit Of Debt - simplywall.st
How to build a custom watchlist for Mirum Pharmaceuticals Inc.Market Risk Report & Daily Stock Momentum Reports - newser.com
How to integrate Mirum Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Why Mirum Pharmaceuticals Inc. stock remains undervalued2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Will Livmarli Continue to Drive Mirum's Top Line in Q3 Earnings? - Yahoo Finance
How to use a screener to detect Mirum Pharmaceuticals Inc. breakoutsProduct Launch & Real-Time Chart Pattern Alerts - newser.com
Volume spikes in Mirum Pharmaceuticals Inc. stock – what they mean2025 Trade Ideas & Verified Short-Term Plans - newser.com
Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Up 6.9%Should You Buy? - MarketBeat
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The AI Journal
Is Mirum Pharmaceuticals Inc. reversing from oversold territory2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Mirum Pharmaceuticals' (MIRM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Can Mirum Pharmaceuticals Inc. (08D) stock survive global slowdownInflation Watch & Low Drawdown Investment Ideas - newser.com
Is Mirum Pharmaceuticals Inc 08D a good long term investmentRisk Management Strategies & Affordable Portfolio Trading - earlytimes.in
Will Mirum Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Daily Profit Focused Screening - newser.com
Branded Website for Consumers 2025 - Medical Marketing and Media
Mirum Pharmaceuticals stock hits all-time high at 78.23 USD By Investing.com - Investing.com South Africa
Mirum Pharmaceuticals stock hits all-time high at 78.23 USD - Investing.com
What data driven models say about Mirum Pharmaceuticals Inc.’s futureJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com
Will Mirum Pharmaceuticals Inc. stock recover faster than peersIndex Update & Risk Controlled Daily Trade Plans - newser.com
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 11.68% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
Custom watchlist performance reports with Mirum Pharmaceuticals Inc.2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Is Mirum Pharmaceuticals Inc. stock near bottom after declineDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
Why Mirum Pharmaceuticals Inc. (08D) stock is listed among top recommendationsQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
How sentiment analysis helps forecast Mirum Pharmaceuticals Inc.Sell Signal & AI Enhanced Trading Signals - newser.com
Identifying reversal signals in Mirum Pharmaceuticals Inc.July 2025 Technicals & Daily Entry Point Alerts - newser.com
Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
Is Mirum Pharmaceuticals Inc. forming a bottoming baseQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - newser.com
Price action breakdown for Mirum Pharmaceuticals Inc.Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Mirum Pharmaceuticals Inc (MIRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):